Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Molecular Partners Ag (MOLN) FCF Margin: 2020-2025

Historic FCF Margin for Molecular Partners Ag (MOLN) over the last 5 years, with Sep 2025 value amounting to 19,197,384.71%.

  • Molecular Partners Ag's FCF Margin rose 1439195931.00% to 19,197,384.71% in Q3 2025 from the same period last year, while for Sep 2025 it was -670.40%, marking a year-over-year increase of 278.00%. This contributed to the annual value of -1,206.30% for FY2024, which is 35975.00% down from last year.
  • Latest data reveals that Molecular Partners Ag reported FCF Margin of 19,197,384.71% as of Q3 2025, which was up 2,228,334.00% from -861.55% recorded in Q2 2025.
  • In the past 5 years, Molecular Partners Ag's FCF Margin registered a high of 19,197,384.71% during Q3 2025, and its lowest value of -6,381,267.68% during Q3 2022.
  • Its 3-year average for FCF Margin is 2,287,273.34%, with a median of -838.48% in 2023.
  • As far as peak fluctuations go, Molecular Partners Ag's FCF Margin plummeted by 786,624,866bps in 2022, and later surged by 1,439,195,931bps in 2025.
  • Molecular Partners Ag's FCF Margin (Quarterly) stood at -928.11% in 2021, then skyrocketed by 99,064bps to 62.53% in 2022, then slumped by 90,101bps to -838.48% in 2023, then crashed by 35,390bps to -1,192.38% in 2024, then surged by 1,439,195,931bps to 19,197,384.71% in 2025.
  • Its FCF Margin was 19,197,384.71% in Q3 2025, compared to -861.55% in Q2 2025 and -1,508.83% in Q1 2025.